Nzs Capital, LLC Danaher Corp Transaction History

Nzs Capital, LLC

$2.39 Billion
Q3 2024

A detailed history of Nzs Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Nzs Capital, LLC holds 322,172 shares of DHR stock, worth $74 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares

322,172

Previous 313,014 2.93%

Holding current value

$74 Million

Previous $78.2 Million 14.52%

% of portfolio

3.75%

Previous 3.42%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $2.19 Million - $2.57 Million	9,158 Added 2.93%	322,172 $89.6 Million
Q2 2024 Aug 14, 2024	BUY	$235.51 - $267.98 $4.79 Million - $5.45 Million	20,332 Added 6.95%	313,014 $78.2 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $13.1 Million - $15 Million	58,502 Added 24.98%	292,682 $73.1 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $8.07 Million - $10.2 Million	43,577 Added 22.86%	234,180 $54.2 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $1.51 Million - $1.72 Million	6,459 Added 3.51%	190,603 $47.3 Million
Q2 2023 Aug 11, 2023	BUY	$224.99 - $256.14 $169,867 - $193,385	755 Added 0.41%	184,144 $44.2 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $17.1 Million - $19.7 Million	71,242 Added 63.53%	183,389 $46.2 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $4.18 Million - $4.88 Million	17,299 Added 18.24%	112,147 $29.8 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $819,250 - $5 Million	3,316 Added 3.62%	94,848 $24.5 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $21.7 Million - $27.4 Million	91,532 New	91,532 $23.2 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $167B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nzs Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nzs Capital, LLC with notifications on news.

Account